Journal of cosmetic dermatology · 2017
Bimatoprost ophthalmic solution in facial vitiligo.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Jha Abhijeet K, Prasad Smita, Sinha Rajesh
Аннотация
BACKGROUND: Vitiligo is one of the commonest pigmentary disorders characterized by destruction of melanocytes.
AIM: To evaluate the efficacy of topical bimatoprost ophthalmic solution in stable facial vitiligo.
MATERIAL AND METHODS: Eight cases of stable facial vitiligo were treated with bimatoprost 0.03% ophthalmic solution once daily for 12 weeks. Photographic records were taken at 2 weeks follow-up along with dermoscopic (Polarized, 10×) evaluation.
RESULTS: Four cases had excellent repigmentation, two cases had partial repigmentation and two cases had poor response.
CONCLUSION: Bimatoprost seems to be promising in treating stable vitiligo but large-scale studies are required.
AIM: To evaluate the efficacy of topical bimatoprost ophthalmic solution in stable facial vitiligo.
MATERIAL AND METHODS: Eight cases of stable facial vitiligo were treated with bimatoprost 0.03% ophthalmic solution once daily for 12 weeks. Photographic records were taken at 2 weeks follow-up along with dermoscopic (Polarized, 10×) evaluation.
RESULTS: Four cases had excellent repigmentation, two cases had partial repigmentation and two cases had poor response.
CONCLUSION: Bimatoprost seems to be promising in treating stable vitiligo but large-scale studies are required.